Report cover image

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Publisher GlobalData
Published Apr 06, 2026
Length 48 Pages
SKU # GBDT21065875

Description

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Les Laboratoires Servier SAS (Servier) is advancing therapeutic solutions in oncology, cardio-metabolism, venous diseases, and neurology, with a focus on areas where treatment options are limited, such as digestive cancers, gliomas, and hematological cancers. The company offers a wide range of medicines in cardiometabolism, including Atorduo, Coversyl, and Daflon; in oncology, such as Asparlas, Lonsurf, and Onivyde; and in neurology, including Arcalion, Stablon, and Valdoxan. Its research and development efforts focus on immuno-oncology, targeted therapies, and neurological treatments using antisense oligonucleotides and small molecules. The company operates through production sites and research centers in Boston, Denmark, and Paris-Saclay. Servier is headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Apr 01,2026: Servier Discusses Changes in the Healthcare Sector at Global Industry
Mar 18,2026: Patient Organizations Address Treatment Adherence
Mar 13,2026: Servier CMO’s offering at the Tianjin site
Mar 09,2026: kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

48 Pages
Section 1 - About the Company
Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Key Employee Biographies
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Les Laboratoires Servier SAS - Business Description
R&D Overview
Les Laboratoires Servier SAS - Corporate Strategy
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Les Laboratoires Servier SAS - Weaknesses
Les Laboratoires Servier SAS - Opportunities
Les Laboratoires Servier SAS - Threats
Les Laboratoires Servier SAS - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 01, 2026: Servier Discusses Changes in the Healthcare Sector at Global Industry
Mar 18, 2026: Patient Organizations Address Treatment Adherence
Mar 13, 2026: Servier CMO’s offering at the Tianjin site
Mar 09, 2026: kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics
Feb 16, 2026: Servier Releases 2024/2025 Annual Report
Jan 27, 2026: Servier Posts Strong 2024/25 Results and Confirms 2030 Forecasts
Jan 27, 2026: Servier Delivers Solid Performance in 2024/25 and Confirms Its Forecasts for 2030
Jan 05, 2026: Insilico and Servier announce $888m oncology research agreement
Sep 30, 2025: Peptisystems Supports Servier’s First Step Into In-House Oligonucleotide Synthesis
Sep 09, 2025: Servier to acquire potential Fragile X syndrome treatment from Kaerus
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Key Employee Biographies
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Les Laboratoires Servier SAS, Recent Deals Summary
List of Figures
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.